title: Towards an individualised target concentration of adalimumab in rheumatoid arthritis.
authors.affiliation: Université François-Rabelais de Tours, CNRS, UMR 7292, Tours, France Service de Rhumatologie, CHRU de Tours, Tours, France.
authors.forename: Emilie
authors.initials: E
authors.lastname: Ducourau
authors.affiliation: Université François-Rabelais de Tours, CNRS, UMR 7292, Tours, France Laboratoire de Pharmacologie-Toxicologie, CHRU de Tours, Tours, France.
authors.forename: David
authors.initials: D
authors.lastname: Ternant
authors.affiliation: Université de Rouen, INSERM U905 & CIC/CRB0204, Rouen, France Service de Rhumatologie, CHRU de Rouen, Rouen, France.
authors.forename: Thierry
authors.initials: T
authors.lastname: Lequerré
authors.affiliation: Université François-Rabelais de Tours, CNRS, UMR 7292, Tours, France Service de Rhumatologie, CHRU de Tours, Tours, France.
authors.forename: Piéra
authors.initials: P
authors.lastname: Fuzibet
authors.affiliation: Université de Rouen, INSERM U905 & CIC/CRB0204, Rouen, France Service de Rhumatologie, CHRU de Rouen, Rouen, France.
authors.forename: Xavier
authors.initials: X
authors.lastname: Le Loët
authors.affiliation: Université François-Rabelais de Tours, CNRS, UMR 7292, Tours, France Laboratoire d'Immunologie, CHRU de Tours, Tours, France.
authors.forename: Hervé
authors.initials: H
authors.lastname: Watier
authors.affiliation: Université François-Rabelais de Tours, CNRS, UMR 7292, Tours, France Service de Rhumatologie, CHRU de Tours, Tours, France.
authors.forename: Philippe
authors.initials: P
authors.lastname: Goupille
authors.affiliation: Université François-Rabelais de Tours, CNRS, UMR 7292, Tours, France Laboratoire de Pharmacologie-Toxicologie, CHRU de Tours, Tours, France.
authors.forename: Gilles
authors.initials: G
authors.lastname: Paintaud
authors.affiliation: Université de Rouen, INSERM U905 & CIC/CRB0204, Rouen, France Service de Rhumatologie, CHRU de Rouen, Rouen, France.
authors.forename: Olivier
authors.initials: O
authors.lastname: Vittecoq
authors.affiliation: Université François-Rabelais de Tours, CNRS, UMR 7292, Tours, France Service de Rhumatologie, CHRU de Tours, Tours, France.
authors.forename: Denis
authors.initials: D
authors.lastname: Mulleman
mesh_terms: D000068879:Adalimumab; D061067:Antibodies, Monoclonal, Humanized / Q000097:blood* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000097:blood* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000097:blood* / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D006801:Humans; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000068879:Adalimumab
keywords: Anti-TNF; Pharmacokinetics; Rheumatoid Arthritis